Wolverine Asset Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Wolverine Asset Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-47,103	Closed	-$1.13M	–	2636
2021 Q1	$1.13M	Buy	+47,103	New	+$875K	0.01%	598

Wolverine Asset Management's GNMK Position: Q2 2021 in Review

Wolverine Asset Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 47,103 shares — an estimated $1.13M sold.

Wolverine Asset Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $1.13M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Wolverine Asset Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Wolverine Asset Management sold 47,103 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.13M.
Wolverine Asset Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
Wolverine Asset Management's GenMark Diagnostics, Inc position peaked at $1.13M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.